Common antibiotic could treat inflammatory bowel disease, new study finds
An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...
This ‘below the button’ disease is hitting too many Australians. Why is no one talking about it?
While the rising incidence is due in part to environmental factors including ultra-processed foods and smoking, the ...
GlobalData on MSN13h
Eli Lilly reports positive data from trial of Omvoh for Crohn’s disease
"Eli Lilly reports positive data from trial of Omvoh for Crohn’s disease" was originally created and published by Clinical ...
TAU makes breakthrough in drug delivery to treat inflammatory bowel disease
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
MedPage Today2d
Risankizumab Tops Competitor for Clinical Remission in Moderate-to-Severe CD
SAN FRANCISCO -- More adults with moderate-to-severe Crohn's disease (CD) reached clinical remission after 6 months on ...
MedPage Today3d
Exclusion Diet in Pediatric Crohn's Tied to Clinical Remission in Small Study
SAN FRANCISCO -- The pediatric Crohn's disease exclusion diet was associated with clinical remission for children with good ...
Everyday Health3d
Ulcerative Colitis Diet: What to Eat and Avoid, 7-Day Meal Plan, More
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...
Malaysian Reserve3d
Most patients on Lilly’s Omvoh® (mirikizumab-mrkz) for Crohn’s disease achieved sustained clinical remission and endoscopic response at two years
More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Nearly 90% of ...
Hosted on MSN4d
AI Prediction System for Idiopathic Multicentric Castleman's Disease
Researchers have used AI to find adalimumab effective for iMCD, highlighting the potential of machine learning in discovering ...
EurekAlert!4d
Crohn's & Colitis Congress® spotlights key IBD research findings
The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are excited to host the annual Crohn’s & Colitis Congress®, taking place Feb. 6-8, in San Francisco, CA. This ...
AI tool helps find life-saving medicine for rare disease
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...